Suel-Kee Kim is an Associate Research Scientist in Neuroscience at the Yale School of Medicine, Yale University. Their research focuses on neurodevelopment, stem cell biology, and cellular mechanisms underlying neurological disorders. Key areas include neural fate determination from pluripotent stem cells, molecular programs in macaque brain development, and transcriptomic analysis of neural differentiation pathways. Notable contributions include studies on cellular recovery post-ischemia, impaired neurogenesis in congenital hydrocephalus, and retinoic acid's role in prefrontal cortex patterning. Collaborations with leading labs like the Sestan Lab emphasize interdisciplinary approaches in neuroscience and regenerative medicine. Publications highlight innovative work in stem cell microenvironment engineering, forensic transcriptomics of flies, and pancreatic islet differentiation for diabetes therapy. Their research bridges basic science and translational applications in neurology and regenerative medicine.
Ben Raphael is a Professor in the Department of Computer Science at Princeton University, with affiliations at the Lewis-Sigler Institute for Integrative Genomics, Omenn-Darling Bioengineering Institute, and Center for Statistics and Machine Learning. He is also an Affiliate Faculty member at the Rutgers Cancer Institute of New Jersey, Irving Institute for Cancer Dynamics at Columbia University, and New York Genome Center. His research focuses on computational methods for analyzing large-scale biological data, emphasizing cancer evolution, network/pathway analysis, and structural variation in genomes. Research Trends: His recent work spans cancer lineage trees, spatial transcriptomics, optimal transport for developmental models, and network analysis of mutations. Articles highlight applications in prostate cancer, pancreatic cancer, and single-cell genomics. Scientific Awards: 2024 ACM Fellow 2023 RECOMB Test of Time Award 2022 RECOMB Test of Time Runner-Up 2021 ISCB Innovator Award 2021 RECOMB Best Paper Runner-Up 2020 ISCB Fellow 2020 AACR Team Science Award 2011 NSF CAREER Award 2013 RECOMB Best Paper 2010-2012 Sloan Research Fellowship Advising: He has mentored numerous Ph.D. students and postdoctoral fellows, many of whom have transitioned to academic and industry roles. Current advisees include Uthsav Chitra, Gillian Chu, and Alexander Strzalkowski. Labs & Teams: Raphael leads the Raphael Lab at Princeton, developing tools like HotNet2, CHISEL, and HATCHet for cancer genomics and network analysis.
Jianping Fu is a Professor in the Department of Mechanical Engineering at the University of Michigan , with joint appointments in Biomedical Engineering and Cell and Developmental Biology. His research integrates micro/nanoengineering , mechanobiology , and stem cell biology to model human development and disease. Education: PhD (MIT, 2007), BE (University of Science and Technology of China, 2000) His research interests focus on stem cell bioengineering , developmental bioengineering , and mechanobiology , particularly in modeling early post-implantation human development, neural tube formation, and pluripotent stem cell mechanoregulation. His work combines biomimetic culture systems with microfluidic gradients to study embryogenesis and organogenesis. Recent publications highlight advances in human embryo modeling (2024 Cell, Nature, Cell Stem Cell), neural tube patterning (2024 Nature), and mechanobiology of stem cells (2024 Nature Reviews Physics). These studies emphasize computational methods , single-cell analysis , and standardization of embryo models . Scientific honors include: Friedrich Wilhelm Bessel Research Award (2022) ISSCR Merit Award (2024) Fellow, American Institute for Medical and Biological Engineering (2019) NSF CAREER Award (2012) Life Member, World Association of Chinese Biomedical Engineers (2024) Dr. Fu mentors extensively, with 20+ alumni including PhD students and postdocs now in academic and industry positions. His lab has received $3M NIH funding for immunological diagnostics and MTRAC grants for translational research. Collaborations with institutions like Cincinnati Children's Hospital and Rice University enhance his interdisciplinary approach to regenerative medicine.
David A. Tirrell serves as Provost and holds the Ross McCollum-William H. Corcoran Professorship in Chemistry and Chemical Engineering at the California Institute of Technology. He earned his B.S. (1974) from MIT, M.S. (1976) and Ph.D. (1978) from the University of Massachusetts at Amherst, and received an honorary doctorate (D.h.c.) from Eindhoven Technical University. Chair, Division of Chemistry and Chemical Engineering (1999-2009) Director, Beckman Institute (2012-2018) Provost (2017-present) His research focuses on macromolecular chemistry and genetic code reengineering to incorporate non-canonical amino acids into proteins. This work enables novel approaches to biomaterials design , proteomic analysis , and protein evolution with applications in tissue regeneration and molecular imaging . Recent publications highlight 3D-printable cellular composites , engineered bacterial films , and non-canonical amino acid applications in medical contexts. Scientific recognitions include election to: American Academy of Arts and Sciences American Philosophical Society All three branches of U.S. National Academies (Sciences, Engineering, and Medicine) As principal investigator of the Tirrell Lab , he has mentored numerous students and researchers like Sophie Miller, Hanwei Liu, and Grace Wang, whose work spans synthetic biology , genetic code modification , and advanced proteomic techniques .
Dr. Gabriella Lindberg is an Assistant Professor in the Department of Bioengineering at the University of Oregon's Knight Campus, leading the Lindberg Lab. Her research focuses on developing bioinks, hydrogels, and bioresins to engineer musculoskeletal tissues that replicate native biological environments. She holds a PhD from the University of Otago and previously served as a Research Fellow in the Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group. Dr. Lindberg has secured significant grants, including a New Zealand Health Research Council Emerging Researcher Grant, and has won multiple awards such as the ISBF Young Investigator Award (2019) and CMDT/MedTech CoRE awards. Her work spans collaborative projects with institutions in New Zealand, Germany, Netherlands, and Australia. Current lab members include researchers like Vinni Thoms (Lab Manager) and Tim Wheeler (Postdoctoral Scholar). The lab is recruiting for postdoctoral and graduate positions in immunomodulation for osteoarthritis and bone marrow tissue engineering. Key research platforms include biofabrication, biomaterials, and organoid development. Dr. Lindberg’s research emphasizes clinical relevance, with projects addressing patient variability and disease progression modeling. Her team explores oxygen control in 3D-printed constructs and integrates inflammatory biology with biomaterials science. The lab’s long-term goals include advancing 3D bioassembly for musculoskeletal repair and hematological disease treatments. Notable contributions include work on vitreous humor as a biomaterial, automated 3D bioassembly, and the development of photoclickable gelatin bioinks. She has mentored numerous students, including PhD candidates Axel Norberg and Bram Soliman, and supervised master’s and undergraduate researchers in tissue engineering and biofabrication techniques.
Xavier Trepat is an ICREA Research Professor and Group Leader at the Institute for Bioengineering of Catalonia (IBEC), affiliated with the University of Barcelona. His academic journey includes a BSc in Physics (2000), a BSc in Engineering (2001), and a PhD in Medical Sciences (2004) from the University of Barcelona. He conducted postdoctoral research at Harvard University and later held positions at the University of Barcelona and IBEC, becoming an ICREA Research Professor in 2011. His research focuses on mechanobiology, integrating physics and biology to study cellular and tissue dynamics. Key areas include cytoskeletal mechanics, collective cell migration, cancer metastasis, and organoid engineering. He has pioneered techniques like traction force microscopy and microfluidic platforms (e.g., MIRO chip) to model tumor-stroma interactions. Recent work highlights include uncovering mechanical signaling pathways (YAP/TAZ-TEAD), the role of nuclear mechanics in cancer, and the development of 3D tissue models. His studies on durotaxis and collective cell migration have advanced understanding of how cells sense and respond to mechanical cues. Collaborations span institutions like Harvard, MIT, and leading research centers globally.
Stelios Andreadis is the SUNY Distinguished Professor of Chemical and Biological Engineering at the University at Buffalo, affiliated with the School of Engineering and Applied Sciences. He directs the Cell, Gene and Tissue Engineering Center and previously led the Stem Cells in Regenerative Medicine (SCiRM) Training Program. His research focuses on stem cell bioengineering, vascular and gland tissue engineering, and biomaterials design. He holds a PhD in Chemical Engineering from the University of Michigan and has been funded by NIH, NSF, and NYSTEM, totaling over $20M. His awards include the NSF CAREER Award, SUNY Chancellor’s Excellence in Scholarship, and AIMBE and BMES Fellowships. Research interests span stem cell rejuvenation, cell-free vascular grafts, and metabolic reprogramming. He has published 140+ papers and advised 28 PhD students, many now in academia or industry. His lab co-founded Angiograft, LLC to commercialize vascular grafts. Key achievements include developing self-healing vascular grafts and demonstrating monocyte recruitment for vascular regeneration. His work bridges basic science and clinical applications in regenerative medicine.
Prof. Elisabeth Engel López leads the Biomaterials for Regenerative Therapies group at the Institute for Bioengineering of Catalonia (IBEC) and serves as a Professor at the Technical University of Catalonia. With over 80 publications in JCR journals, her work focuses on designing biomaterials and scaffolds for in vitro/in vivo regenerative medicine, emphasizing cellular response mechanisms and translational applications. Developing lactate-releasing systems for metabolic modulation Advancing 3D bioprinting for tissue-specific models Engineering angiogenic and osteogenic biomaterials Her research bridges fundamental studies with industrial partnerships, including pharmaceutical and biomedical device companies, and contributes to European collaborative projects. She received the Barcelona City Award for technological research and has delivered numerous invited lectures. Her group explores substrate stiffness, ion release, and microenvironmental cues to control cell behavior in cardiac, neural, and bone regeneration contexts.
Jinhong Meng is a Senior Research Fellow at the Department of Genetics & Genomic Medicine, University College London (UCL), focusing on neuromuscular disorders and gene therapy. He earned his PhD and Bachelor’s degrees from the Fourth Military Medical University. Education: Doctor of Philosophy, Fourth Military Medical University (2000) Bachelor, Fourth Military Medical University (1995) Research Interests: Jinhong Meng’s work centers on Duchenne Muscular Dystrophy (DMD), Spinal Muscular Atrophy (SMA), and gene therapy techniques including CRISPR, lentiviral vectors, and antisense oligonucleotides. His studies explore immune responses to dystrophin, vascular defects in SMA, and dystrophin correction via viral and non-viral delivery systems. Publication Trends: Over the past eight years, Jinhong Meng has published extensively on DMD and SMA, with a focus on gene editing, dystrophin restoration, and cellular therapies. His collaborative work spans lentiviral vectors, foamy virus transduction, and necroptosis mechanisms in muscle degeneration. Labs & Collaborations: He works within UCL’s Genetics & Genomic Medicine Department, collaborating on projects involving dystrophic muscle engraftment, circadian signaling, and RNA editing for genetic mutations.
Arnaud Bertsch is a Lecturer at the École Polytechnique Fédérale de Lausanne (EPFL) within the School of Engineering (STI) and the Department of Microengineering (IEM). He is affiliated with the Microsystems Laboratory 1 (LMIS1) and has been actively involved in teaching advanced microfabrication techniques and MEMS sensor/actuator practicals. His research spans microfluidics, nanofluidics, biomedical devices, and 3D microfabrication, with a focus on neural probes, drug delivery systems, and cell manipulation technologies. Microfluidic hydrodynamic and dielectrophoretic systems Nanovolcano microelectrode arrays for electrophysiology Thermal control of ionic transport in nanochannels 3D lipid microrobots for drug delivery MEMS-based intraocular pressure sensors Arnaud Bertsch has supervised PhD students including Torres Vila Pol, Zhang Tao, and past advisees like Clémentine Lipp, Nicolas Maïno, and Joan Teixidor. His work bridges fundamental research in nanofluidics with applied biomedical solutions, contributing to fields such as neuroscience, cancer therapy, and implantable medical devices. The articles listed demonstrate expertise in microsystem design, electrochemical sensing, and biofabrication technologies.
Woojin Han is an Assistant Professor in the Departments of Orthopedics and Cell, Developmental & Regenerative Biology at the Icahn School of Medicine at Mount Sinai. His research program focuses on the mechanobiology of skeletal muscle stem and progenitor cells, with applications in disease modeling and the development of advanced therapeutics for muscle injuries and degenerative diseases. Dr. Han earned his BS in Biomedical Engineering from the University of Rochester and his MS and PhD in Bioengineering from the University of Pennsylvania. He completed his postdoctoral training at the Georgia Institute of Technology, where he received awards from the American Federation for Aging Research (AFAR) and the NIH. Dr. Han's research integrates biomaterials, bioengineering, and in vivo genetic approaches to investigate cell-matrix interactions and mechanobiological signaling, aiming to uncover the mechanisms driving muscle regeneration and pathology. His work is supported by the National Institutes of Health (NIH) and the Department of Defense (DoD). Analysis of Dr. Han's recent publications reveals a strong focus on muscle regeneration mechanisms, particularly examining the role of extracellular matrix proteins, mechanical confinement, and signaling pathways in muscle stem cell behavior. His research spans from fundamental mechanobiology to translational applications using biomaterials for tissue regeneration. 2025 NEBEC Emerging Investigator Award 2024 Mount Sinai Faculty Council Award for Junior Faculty 2023 Popular Science's The Brilliant 10 2022 Stephen I. Katz Early Stage Investigator Grant Awardee American Federation for Aging Research (AFAR) award NIH award Dr. Han's research is supported by significant funding from the National Institutes of Health (NIH) and the Department of Defense (DoD). His work bridges basic science and clinical applications, with particular emphasis on developing advanced therapeutics for muscle injuries and degenerative diseases. Through his lab, he mentors junior researchers in the fields of biomechanics, bioengineering, and regenerative medicine. Dr. Han leads the Han Lab, which focuses on skeletal muscle regeneration research. The lab employs a multidisciplinary approach combining biomaterials engineering, molecular biology, and advanced imaging techniques to develop novel strategies for enhancing muscle repair and preventing pathological changes following injury.
Justin Milner, PhD, serves as Assistant Professor in the Department of Microbiology and Immunology at the University of North Carolina at Chapel Hill School of Medicine and is a member of the UNC Lineberger Comprehensive Cancer Center. His research develops novel approaches to enhance cancer immunotherapies through multi-omics and bioengineering techniques. Education: Postdoctoral Fellowship, UCSD PhD, UNC Chapel-Hill BS, UNC Chapel-Hill Dr. Milner's lab investigates molecular drivers of T cell differentiation and function within tumor microenvironments, utilizing cutting-edge genomics, bioengineering, and computational immunology. His work focuses on reprogramming T cell activity to overcome immunotherapy resistance in cancers, with particular emphasis on epigenetic regulation and metabolic adaptations of tumor-infiltrating lymphocytes. Recent projects explore hydrogel-based delivery systems for immunotherapeutics and transcriptional networks governing T cell exhaustion. Analysis of his 15 most recent publications reveals dominant themes in cancer immunotherapy enhancement, particularly through T cell engineering (7/15 articles), tumor microenvironment modulation (5/15), and computational approaches to T cell biology (3/15). Key methodologies include single-cell multi-omics, in vivo screening, and biomaterial-based drug delivery systems targeting solid tumors. Scientific Awards: NIH NCI K99/R00 Pathway to Independence Award V Foundation Scholar Award Lung Cancer Initiative Career Development Award UNC Lineberger Innovation Award Multiple institutional pilot awards including Hirschberg Foundation and Mary Kay Ash Awards Dr. Milner currently advises three graduate students and multiple postdoctoral researchers while leading an NIH-funded R01 project ($2.79 million) investigating epigenetic regulation of T cell exhaustion. His lab maintains active collaborations across computational medicine and pancreatic cancer research programs at UNC. The Milner Lab operates within the UNC Lineberger Comprehensive Cancer Center, utilizing core facilities for single-cell genomics, murine tumor modeling, and bioengineering. Current team includes seven researchers focused on T cell reprogramming strategies for solid tumor immunotherapy.
Guillermo A. Ameer serves as the Daniel Hale Williams Professor of Biomedical Engineering at Northwestern University's McCormick School of Engineering and Professor of Surgery in the Feinberg School of Medicine. He directs the Center for Advanced Regenerative Engineering (CARE) and maintains affiliations with the Simpson-Querrey Institute, Chemistry of Life Processes Institute, and the IBiS Graduate Program. His leadership extends to founding the Regenerative Engineering Laboratory, which pioneered citrate-based antioxidant biomaterials known as polydiolcitrates. Americas' leading innovator in regenerative engineering, Ameer's research spans vascular, orthopaedic, and bladder tissue engineering. His lab developed Nanonets™ thermoresponsive oligomers and photoresponsive liquid polymers for applications including wound healing, islet transplantation, and 3D-printed vascular scaffolds. Notable breakthroughs include bioresorbable stents, bladder regeneration scaffolds, and diabetic wound healing technologies that have received FDA clearance and commercial implementation through companies like Acuitive Technologies and VesselTek BioMedical. His publication record demonstrates consistent innovation in biomaterials science, with research trends showing progression from fundamental polymer chemistry to sophisticated clinical applications. Recent work focuses on electroactive bladder scaffolds, 3D-printed vascular devices, and wearable health monitoring systems, reflecting his commitment to translating laboratory discoveries into tangible medical solutions. The 2025 launch of the Regenerative Engineering Institute underscores his growing institutional impact. Percy L. Julian Award (2024) BMES Athanasiou Medal of Excellence in Translational Bioengineering (2023) Election to National Academy of Medicine (2021) National Academy of Inventors Fellow (2019) AAAS Fellow (2018) AIChE Fellow (2017) Ameer has mentored over 30 PhD and Master's students who now lead research at institutions including Penn State, USC, and the FDA. His lab secures substantial NIH funding, including an American Recovery and Reinvestment Act Challenge Grant for liquid cast arterial stents. Current projects include the development of citrate-based biomaterials for bladder regeneration, diabetic wound healing, and bioresorbable vascular scaffolds, with multiple technologies transitioning to clinical applications through partnerships with medical device companies. The Regenerative Engineering Laboratory maintains a collaborative interdisciplinary environment with approximately 20 researchers spanning engineering and natural sciences disciplines. Recent initiatives include the development of wearable skin gas sensors (2025) and CITREPORE™ bone void filler (2024), demonstrating the lab's capacity to address diverse clinical challenges through biomaterials innovation.
Prof Wen Wang is Professor of Biomedical Engineering and Vice-Principal and Executive Dean for Science and Engineering at Queen Mary University of London, affiliated with the School of Engineering and Materials Science and the Centre for Bioengineering. He is a Chartered Engineer and holds fellowships from the Institution of Mechanical Engineers (FIMechE), Higher Education Academy (FHEA), American Institute for Medical and Biological Engineering (FAIMBE), and the Royal Academy of Engineering (FREng), reflecting his leadership and technical excellence in engineering and biomedical sciences. His research focuses on vascular bioengineering , biomaterial mechanics , and cell biomechanics , with particular emphasis on the endothelial glycocalyx , vascular stem cells , and transmembrane transport . He employs advanced techniques such as AFM nano-indentation, confocal microscopy, and microfluidic platforms to study the mechanical properties, shear stress responses, and structural stability of biological systems. His work spans from fundamental biophysics to translational applications in drug delivery and cardiovascular disease. Prof Wang has led multidisciplinary research projects in the UK and through international collaborations with partners in the US, China, and Japan. His recent publications highlight sustained contributions to understanding microcapsule mechanics , extracellular vesicles , biofluid dynamics , and biomolecular sensing . His work integrates experimental and computational modeling, particularly in microcirculation and cellular transport phenomena. He has received notable scientific recognition through multiple prestigious fellowships and has published extensively in high-impact journals including Nature Communications , Journal of Controlled Release , Biosensors and Bioelectronics , and Journal of Fluid Mechanics . His research demonstrates a strong trajectory in both fundamental discovery and applied biomedical innovation. Prof Wang actively supervises research and collaborates with clinical and engineering partners at Queen Mary and King's College London. His leadership in the School of Engineering and Materials Science underscores his role in shaping academic strategy and research excellence in science and engineering at Queen Mary University of London.
Dr. Lin Su is a Lecturer in Engineering Biology at Queen Mary University of London, leading the Biohybrids group. His research focuses on biohybrid systems in synthetic biology, particularly electron transfer mechanisms between microorganisms and materials, with applications in bioelectrical systems and artificial photosynthesis. Dr. Su holds a PhD in Biomedical Engineering from Southeast University (2021), with postdoctoral research at the University of Cambridge (2021–present). His work includes collaborations with Lawrence Berkeley National Lab and Rice University (2016–2021). He is a Leverhulme Early Career Fellow (2022–2025) and an Isaac Newton Trust Grant recipient. He also serves as a Fellow at Lucy Cavendish College, Cambridge. Research interests span synthetic biology, microbial-material interfaces, and energy-related bioengineering. His lab develops novel platforms integrating living and non-living components for sustainable technologies. Awards: Leverhulme Early Career Fellowship Isaac Newton Trust Grant Fellow of Lucy Cavendish College Grants: Collaborative funding via Leverhulme Trust and Isaac Newton Trust. Labs/Teams: Director of the Biohybrids Group (https://biohybrids.group/), focusing on interdisciplinary engineering-biology research.
